Acadia Healthcare Company Inc (NASDAQ: ACHC)’s stock price has increased by 3.74 compared to its previous closing price of 21.63. However, the company has seen a -4.59% decrease in its stock price over the last five trading sessions. accessnewswire.com reported 2025-06-03 that NEW YORK, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or “the Company”) (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ACHC.
Is It Worth Investing in Acadia Healthcare Company Inc (NASDAQ: ACHC) Right Now?
Acadia Healthcare Company Inc (NASDAQ: ACHC) has a price-to-earnings ratio of 11.01x that is above its average ratio. Additionally, the 36-month beta value for ACHC is 0.95. There are mixed opinions on the stock, with 9 analysts rating it as a “buy,” 1 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for ACHC is 89.46M and currently, short sellers hold a 10.72% ratio of that float. The average trading volume of ACHC on June 04, 2025 was 2.64M shares.
ACHC’s Market Performance
ACHC’s stock has seen a -4.59% decrease for the week, with a -3.73% drop in the past month and a -26.33% fall in the past quarter. The volatility ratio for the week is 3.41%, and the volatility levels for the past 30 days are at 3.77% for Acadia Healthcare Company Inc The simple moving average for the last 20 days is -6.78% for ACHC stock, with a simple moving average of -48.39% for the last 200 days.
Analysts’ Opinion of ACHC
Many brokerage firms have already submitted their reports for ACHC stocks, with Barclays repeating the rating for ACHC by listing it as a “Equal Weight.” The predicted price for ACHC in the upcoming period, according to Barclays is $35 based on the research report published on February 28, 2025 of the current year 2025.
KeyBanc Capital Markets, on the other hand, stated in their research note that they expect to see ACHC reach a price target of $70. The rating they have provided for ACHC stocks is “Overweight” according to the report published on January 07th, 2025.
Deutsche Bank gave a rating of “Buy” to ACHC, setting the target price at $75 in the report published on December 12th of the previous year.
ACHC Trading at -10.49% from the 50-Day Moving Average
After a stumble in the market that brought ACHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -72.77% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACHC starting from Hollinsworth John S., who proposed sale 20,000 shares at the price of $53.02 back on Aug 30 ’24. After this action, Hollinsworth John S. now owns shares of Acadia Healthcare Company Inc, valued at $1,060,339 using the latest closing price.
Hollinsworth John S., the Officer of Acadia Healthcare Company Inc, proposed sale 10,000 shares at $81.21 during a trade that took place back on Aug 29 ’24, which means that Hollinsworth John S. is holding shares at $812,065 based on the most recent closing price.
Stock Fundamentals for ACHC
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.63 for the gross margin
The net margin for Acadia Healthcare Company Inc stands at 0.06. The total capital return value is set at 0.07. Equity return is now at value 6.35, with 3.22 for asset returns.
Based on Acadia Healthcare Company Inc (ACHC), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 0.76. The interest coverage ratio of the stock is 3.44.
Currently, EBITDA for the company is 607.84 million with net debt to EBITDA at 4.17. When we switch over and look at the enterprise to sales, we see a ratio of 1.36. The receivables turnover for the company is 7.96for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.35.
Conclusion
In conclusion, Acadia Healthcare Company Inc (ACHC) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
